Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACB
3451
Aurora Cannabis
ACB
$180M
| $5.3M | ﹤0.01% |
63,810
+11,553
| +22% | +$842K |
|
|
VNE
3452
DELISTED
Veoneer, Inc.
VNE
| $5.3M | ﹤0.01% |
248,768
+48,699
| +24% | +$922K |
|
3453
Sally Beauty Holdings
SBH
$1.48B
| $5.3M | ﹤0.01% |
406,103
+162,854
| +67% | +$1.74M |
|
3454
PUT
MP Materials
MP
$8.53B
| $5.29M | ﹤0.01% |
164,400
-27,300
| -14% | -$528K |
|
|
DM
3455
CALL
DELISTED
Desktop Metal, Inc.
DM
| $5.29M | ﹤0.01% |
30,750
+21,860
| +246% | +$2.89M |
|
|
VRNT
3456
CALL
DELISTED
Verint Systems
VRNT
| $5.29M | ﹤0.01% |
154,488
-1,374
| -0.9% | -$39K |
|
3457
PUT
GSK
GSK
$103B
| $5.28M | ﹤0.01% |
114,720
-8,640
| -7% | -$397K |
|
3458
CALL
Meritage Homes
MTH
$4.88B
| $5.28M | ﹤0.01% |
127,400
+94,000
| +281% | +$4.44M |
|
3459
CALL
SBA Communications
SBAC
$18.9B
| $5.28M | ﹤0.01% |
18,700
-32,500
| -63% | -$9.54M |
|
3460
CALL
Magna International
MGA
$19.2B
| $5.28M | ﹤0.01% |
74,500
+24,600
| +49% | +$1.45M |
|
|
JBTM
3461
JBT Marel
JBTM
$6.35B
| $5.27M | ﹤0.01% |
46,302
+7,426
| +19% | +$766K |
|
3462
CALL
Takeda Pharmaceutical
TAK
$53.4B
| $5.27M | ﹤0.01% |
289,651
-258,549
| -47% | -$4.54M |
|
3463
CALL
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $5.27M | ﹤0.01% |
93,700
-18,600
| -17% | -$1.02M |
|
|
DM
3464
PUT
DELISTED
Desktop Metal, Inc.
DM
| $5.27M | ﹤0.01% |
30,620
+22,640
| +284% | +$3M |
|
3465
McCormick & Company Non-Voting
MKC
$14.1B
| $5.26M | ﹤0.01% |
+55,010
| New | +$5.19M |
|
3466
ePlus
PLUS
$2.47B
| $5.25M | ﹤0.01% |
119,480
-12,756
| -10% | -$510K |
|
3467
iShares MSCI USA Momentum Factor ETF
MTUM
$26.3B
| $5.25M | ﹤0.01% |
+32,520
| New | +$4.98M |
|
3468
Trip.com Group
TCOM
$28.9B
| $5.24M | ﹤0.01% |
155,400
-290,558
| -65% | -$9.47M |
|
|
WRK
3469
PUT
DELISTED
WestRock Company
WRK
| $5.24M | ﹤0.01% |
120,400
-50,300
| -29% | -$2.08M |
|
3470
Alamos Gold
AGI
$13.1B
| $5.24M | ﹤0.01% |
598,675
-215,605
| -26% | -$1.91M |
|
|
PHICU
3471
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
| $5.22M | ﹤0.01% |
+500,000
| New | +$5.15M |
|
3472
First Trust Preferred Securities and Income ETF
FPE
$6.35B
| $5.22M | ﹤0.01% |
+258,448
| New | +$5.11M |
|
3473
Innovator US Equity Buffer ETF September
BSEP
$216M
| $5.22M | ﹤0.01% |
179,042
+158,684
| +779% | +$4.44M |
|
3474
Community Health Systems
CYH
$416M
| $5.22M | ﹤0.01% |
702,078
+649,478
| +1,235% | +$4.59M |
|
|
INZY
3475
DELISTED
Inozyme Pharma
INZY
| $5.21M | ﹤0.01% |
252,542
+11,464
| +5% | +$273K |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.